Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Erlotinib Hydrochloride Market Data Survey Report 2025

Single User: $2195
Multiple User: $3195
Enterprise User: $4195

Report Summary:

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market will reach xxx Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Schwarz Pharma
Dr. Reddys Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Zuellig Pharma
Major applications as follows:
Non-small Cell Lung Cancer
Pancreatic Cancer
Regional market size, production data and export & import:
North America
South America
Middle East & Africa

Table of Contents / Index:

Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Roche
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Cipla
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Mylan
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Teva
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 OSI Pharmaceuticals
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Glenmark Pharmaceuticals
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 Beacon Pharmaceuticals
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Raichem Lifesciences
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 United Biotech
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 CJ Corporation
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Vivimed Labs
3.12 Boryung Pharmaceutical
3.13 Taj Pharmaceuticals
3.14 Pharmascience
3.15 Natco Pharma
3.16 Intas Pharmaceuticals
3.17 RPG Life Sciences
3.18 Pharmascience
3.19 Schwarz Pharma
3.20 Dr. Reddys Laboratories
3.21 Glenmark Pharmaceuticals
3.22 Chugai Pharmaceutical
3.23 DKSH
3.24 Firma Chun Cheong
3.25 Kremers Urban Pharmaceuticals
3.26 Ortat
3.27 Zuellig Pharma
4 Major Application
4.1 Non-small Cell Lung Cancer
4.1.1 Overview
4.1.2 Non-small Cell Lung Cancer Market Size and Forecast
4.2 Pancreatic Cancer
4.2.1 Overview
4.2.2 Pancreatic Cancer Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Email ID:

Name of Company:




Please Enter Captcha Below:

Report Details:

Report ID: 33892

Category: 16

Published date: 2017-09-25 14:31:27

Number of Pages: 128

Publisher Name: HeyReports

Over all Rating: 80 % (Average of Ratings provided by clients)